Lippo China Resources Sets March Board Meeting to Approve 2025 Results and Consider Final Dividend

An update from Lippo China Resources Limited ( (HK:0156) ) is now available.

Lippo China Resources Limited has scheduled a board meeting for 31 March 2026 at its Hong Kong headquarters to review and approve the consolidated final results for the financial year ended 31 December 2025. The board will also consider whether to recommend a final dividend, a decision that could affect shareholder returns and signal management’s view of the company’s financial health.

The announcement underscores routine yet important governance processes, as the approval of annual results will provide investors with a detailed view of the group’s performance over the past year. Any dividend recommendation, if made, will be closely watched by stakeholders as an indicator of earnings strength, capital allocation priorities and confidence in the company’s future prospects.

The most recent analyst rating on (HK:0156) stock is a Hold with a HK$0.87 price target. To see the full list of analyst forecasts on Lippo China Resources Limited stock, see the HK:0156 Stock Forecast page.

More about Lippo China Resources Limited

Lippo China Resources Limited is a Hong Kong-incorporated company listed on the Stock Exchange of Hong Kong. It operates through a board comprising executive, non-executive and independent non-executive directors, reflecting a diversified governance structure and oversight of its business interests in the region.

Average Trading Volume: 51,580

Technical Sentiment Signal: Buy

Current Market Cap: HK$881.9M

For a thorough assessment of 0156 stock, go to TipRanks’ Stock Analysis page.